Island Pharmaceuticals Limited (ASX:ILA)
Australia
· Delayed Price · Currency is AUD 0.385
-0.010 (-2.53%)
Apr 29, 2026, 12:58 PM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 116.75 million as of April 28, 2026. Its market cap has increased by 192.26% in one year.
Market Cap
116.75M
Enterprise Value
109.89M
Revenue
62.85K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 116.75M, an increase of 174.66%. That is a compound annual growth rate of 22.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 116.75M | 0.92% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 103.16M |
| Alterity Therapeutics | 119.63M |
| Paradigm Biopharmaceuticals | 101.65M |
| Arovella Therapeutics | 93.08M |
| Botanix Pharmaceuticals | 89.77M |
| Amplia Therapeutics | 84.66M |
| Cynata Therapeutics | 83.11M |
| Recce Pharmaceuticals | 153.27M |